News
Keywords: methylprednisolone sodium succinate, ISSNHL, ADRs, evidence-based medicine, clinical management Citation: Wu T, Tang Y, Yan S, Meng J, He S and Meng W (2025) Characteristics of adverse drug ...
Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025 ...
About LUMRYZ™ (sodium oxybate) for extended-release oral suspension LUMRYZ is an extended-release sodium oxybate medication approved by the FDA on May 1, 2023, as the first and only once-at ...
We Tested an Electric Salt Spoon That Might Help You Stick to Your Low-Sodium Diet The Kirin Electric Salt Spoon at CES 2025 will add a salty taste to your food, though it shocks your tongue to do it.
The Department of Pharmaceuticals (DoP) has rejected an application of Mumbai-based Neon Laboratories to review the National Pharmaceutical Pricing Authority's (NPPA) ceiling price fixation for ...
Find information on cost and hydrocortisone sodium succinate injections, how generic and brand-name prices compare, what financial assistance may be available, and more.
Sodium oxybate was significantly more effective at reducing symptoms than placebo for patients with alcohol-responsive LD but not those whose symptoms do not improve with alcohol.
Methylprednisolone is a prescription drug used to reduce inflammation. Find out about possible interactions with alcohol, other drugs, foods, and health conditions.
Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results